BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $66 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Luca Issi lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $66.00 (from $70.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
